Download
s00210-020-01993-0.pdf 648,60KB
WeightNameValue
1000 Titel
  • Between two stools? Pharmacologists nominated for Nobel prizes in “physiology or medicine” and “chemistry” 1901–1950 with a focus on John Jacob Abel (1857–1938)
1000 Autor/in
  1. Pohar, Michael |
  2. Hansson, Nils |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-10-15
1000 Erschienen in
1000 Quellenangabe
  • 394(3):503-513
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00210-020-01993-0 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892506/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Since the early stages of its academic professionalization, pharmacology has been an interdisciplinary field strongly influenced by the natural sciences. Using the Nobel Prize as a lens to study the history of pharmacology, this article analyzes nominations of pharmacologists for two Nobel Prize categories, namely 'chemistry' and 'physiology or medicine' from 1901 to 1950. Who were they? Why were they proposed, and what do the Nobel dossiers say about excellence in pharmacology and research trends? This paper highlights the evaluation of 'shortlisted' candidates, i.e., those candidates who were of particular interest for the members of the Nobel Committee in physiology or medicine. We focus on the US scholar John Jacob Abel (1857-1938), repeatedly referred to as the 'Founder of American Pharmacology.' Nominated 17 times in both categories, Abel was praised by his nominators for both basic research as well as for his influential positions as editor and his work as chair at Johns Hopkins University. The Abel nominations were evaluated for the Nobel Committee in chemistry by the Swedish professor of chemistry and pharmaceutics Einar Hammarsten (1889-1968), particularly interested in Abel's work on hormones in the adrenal glands and in the pituitary gland. Eventually, Hammarsten did not view Abel's work prizeworthy, partly because other scholars had done-according to Hammarsten-more important discoveries in the same fields. In conclusion, analyses of Nobel Prize nominations help us to better understand various meanings of excellence in pharmacology during the twentieth century and beyond.
1000 Sacherschließung
lokal History of Medicine [MeSH]
lokal Nobel Prize [MeSH]
lokal Pharmacology
lokal Nobel prize
lokal Pharmacology/history [MeSH]
lokal Artificial kidney
lokal Epinephrine
lokal Original Article
lokal Physiology/history [MeSH]
lokal History, 19th Century [MeSH]
lokal Chemistry/history [MeSH]
lokal John Jacob Abel
lokal Excellence in pharmacology
lokal History, 20th Century [MeSH]
lokal Posterior pituitary hormones
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UG9oYXIsIE1pY2hhZWw=|https://orcid.org/0000-0003-0167-4763
1000 Hinweis
  • DeepGreen-ID: 4b58f75b973c4a4d8f700e4d60015465 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6466394.rdf
1000 Erstellt am 2023-11-16T22:49:32.067+0100
1000 Erstellt von 322
1000 beschreibt frl:6466394
1000 Zuletzt bearbeitet 2023-12-01T04:10:34.860+0100
1000 Objekt bearb. Fri Dec 01 04:10:34 CET 2023
1000 Vgl. frl:6466394
1000 Oai Id
  1. oai:frl.publisso.de:frl:6466394 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source